Self-reported adherence to treatment and quality of life in mild to moderate acne

Dermatology

Volumn 217, Issue 4, 2008, Pages 309-314

  Jones Caballero, María ^a   Pedrosa, Emilio ^b   Peñas, Pablo F ^a,c  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b Astellas Pharma   (Spain)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Acne; Adherence; Quality of life; Questionnaire; Treatment outcome

Indexed keywords

ANTIBIOTIC AGENT; ERYTHROMYCIN DERIVATIVE; ERYTHROMYCIN ZINC; UNCLASSIFIED DRUG;

ACNE; ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SELF REPORT; SEX DIFFERENCE; UNEMPLOYMENT; UNSPECIFIED SIDE EFFECT;

ACNE VULGARIS; ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADULT; ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; ERYTHROMYCIN; FEMALE; HUMANS; MALE; OINTMENTS; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; SPAIN; TREATMENT OUTCOME; ZINC;

EID: 49549110244     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151441     Document Type: Article

References (23)

1. O'Connor PJ: Improving medication adherence: challenges for physicians, payers, and policy makers. Arch Intern Med 2006;166:1802-1804.
2. Chren MM: Doctor's orders: rethinking compliance in dermatology. Arch Dermatol 2002;138:393-394.
3. Lee I, Maibach H: Pharmionics in dermatology: a review of topical medication adherence. Am J Clin Dermatol 2006;7:231-236.
4. Sokol M, McGuigan K, Verbrugge R, Epstein R: Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43:521-530.
5. Serup J, Lindblad A, Maroti M, Kjellgren K, Niklasson E, Ring L, Ahlner J: To follow or not to follow dermatological treatment - a review of the literature. Acta Derm Venereol 2006;86:193-197.
6. Kenna L, Labbe L, Barrett J, Pfister M: Modeling and simulation of adherence: approaches and applications in therapeutics. AAPS J 2005;7:E390-E407.
7. Honish A, Westerfield W, Ashby A, Momin S, Phillippi R: Health-related quality of life and treatment compliance with diabetes care. Dis Manag 2006;9:195-200.
8. Jones-Caballero M, Chren M, Soler B, Pedrosa E, Penas P: Quality of life in mild to moderate acne: relationship to clinical severity and factors influencing change with treatment. J Eur Acad Dermatol Venereol 2007;21:219-226.
9. Zaghloul SS, Cunliffe WJ, Goodfield MJ: Objective assessment of compliance with treatments in acne. Br J Dermatol 2005;152:1015-1021.
10. Witkowski JA, Parish LC: The assessment of acne: an evaluation of grading and lesion counting in the measurement of acne. Clin Dermatol 2004;22:394-397.
11. Jones-Caballero M, Peñas PF, García-Díez A, Badía X, Chren MM: The Spanish version of Skindex-29. Int J Dermatol 2000;39:907-912.
12. Osborne J, Hutchinson P: The importance of accurate dosage of topical agents: a method of estimating involved area and application to calcipotriol treatment failures. J Eur Acad Dermatol Venereol 2002;16:367-373.
13. Cork M, Britton J, Butler L, Young S, Murphy R, Keohane S: Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol 2003;149:582-589.
14. Carroll C, Feldman S, Camacho F, Balkrishnan R: Better medication adherence results in greater improvement in severity of psoriasis. Br J Dermatol 2004;151:895-897.
15. Garber M, Nau D, Erickson S, Aikens J, Lawrence J: The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care 2004;42:649-652.
16. Pawin H, Chivot M, Beylot C, Faure M, Poli F, Revuz J, Dreno B: Living with acne: a study of adolescents' personal experiences. Dermatology 2007;215:308-314.
17. Richards H, Fortune D, O'Sullivan T, Main C, Griffiths C: Patients with psoriasis and their compliance with medication. J Am Acad Dermatol 1999;41:581-583.
18. Carroll C, Feldman S, Camacho F, Manuel J, Balkrishnan R: Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol 2004;51:212-216.
19. Renzi C, Picardi A, Abeni D, Agostini E, Baliva G, Pasquini P, Puddu P, Braga M: Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance. Arch Dermatol 2002;138:337-342.
20. Jones-Caballero M, Peñas PF, Garcia-Diez A, Chren MM, Badia X: La versión española de Skindex-29: un instrumento de medida de la calidad de vida en pacientes con enfermedades cutáneas. Med Clin (Barc) 2002;118:5-9.
21. Lasek RJ, Chren MM: Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol 1998;134:454-458.
22. Picardi A, Abeni D, Melchi CF, Puddu P, Pasquini P: Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000;143:983-991.
23. Salek S, Roberts A, Finlay AY: The practical reality of using a patient-reported outcome measure in a routine dermatology clinic. Dermatology 2007;215:315-319.